Tata Trusts partners with Telangana to upgrade cancer care Ruby Khatun Khatun3 March 2018 10:30 AM ISTHyderabad: The Telangana government and Tata Trusts signed an MoU to deliver high-quality affordable cancer care through a three-tier model and...
AstraZeneca spins off autoimmune drugs into new biotech company Ruby Khatun Khatun3 March 2018 9:45 AM ISTLONDON: AstraZeneca is spinning off six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune...
Zydus Cadila gets USFDA nod for sedative injection Ruby Khatun Khatun2 March 2018 10:30 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from US health regulator to market Dexmedetomidine Hydrochloride injection used...
Mylan teams up with Revance on biosimilar for Botox Ruby Khatun Khatun2 March 2018 10:00 AM ISTNEW YORK: Mylan NV on Wednesday struck a licensing agreement with Revance Therapeutics Inc to develop a biosimilar of Allergan Plc’s blockbuster Botox...
USFDA rejects filing for Celgene MS drug, shares fall Ruby Khatun Khatun2 March 2018 9:45 AM ISTU.S. health regulators have rejected Celgene Corp’s application seeking approval of key multiple sclerosis drugs due to insufficient data, the company...
NPPA fixes retail prices of 14 formulations, check out details Ruby Khatun Khatun1 March 2018 2:42 PM ISTNew Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
Cipla ties up with Roche to sell 2 cancer drugs in India Ruby Khatun Khatun1 March 2018 10:35 AM ISTNew Delhi: Drug firm Cipla said it has entered into an agreement with Roche Pharma to promote and distribute the latter's cancer drugs in India.The...
Roche wins EU approval for hemophilia drug Hemlibra Ruby Khatun Khatun1 March 2018 10:00 AM ISTZURICH: Swiss group Roche said the European Commission has approved its drug Hemlibra for people with hemophilia A who have developed resistance to...
US subpoenas Mallinckrodt for information on opioid painkillers Ruby Khatun Khatun1 March 2018 9:45 AM ISTPharmaceutical company Mallinckrodt Plc said it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to...
DoP rejects Biocon plea to review ceiling price of Trastuzumab injection Ruby Khatun Khatun28 Feb 2018 5:31 PM ISTThe Department of Pharmaceuticals (DoP) has rejected a review petition filed by Biocon Limited against the price fixation of Trastuzumab Injection -...
Hetero launches fixed dose combination drug for HIV in India Ruby Khatun Khatun28 Feb 2018 10:30 AM ISTNew Delhi: Drug firm Hetero said it has launched generic anti-retroviral fixed-dose combination (FDC) of Emtricitabine (200mg) and Tenofovir...
Strides Shasun to launch Ranitidine tablets in US Ruby Khatun Khatun28 Feb 2018 10:15 AM ISTNew Delhi: Drug firm Strides Shasun announced that it will launch Ranitidine Tablets USP, 150 mg, used to treat peptic ulcers of the stomach and...
